Teva plunges as outlook cut for third time
Company cuts profit forecast a day after new chief executive takes over
Company cuts profit forecast a day after new chief executive takes over
Dane lands top job with beleaguered generics giant after reviving Lundbeck’s fortunes
Results from long-awaited Mystic lung cancer study fail to show hoped-for patient recovery
Pharmaceutical acquisition was announced a year ago with $40.5bn price tag
Pharma group agreed to merge with Pfizer last year to take advantage of Ireland’s lower corporate tax rate
Drugmaker said it fell short of 50% share threshold in tender offer
Israeli drugmaker nearing deal to acquire unit for between $40 billion and $45 billion
Three-way battle sees Irish group Perrigo cast as defensive foil as Mylan looks to avoid the clutches of world’s largest generics group Teva
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices